Characteristics and Outcome of
Journal
Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
15
10
2019
revised:
18
12
2019
accepted:
10
01
2020
pubmed:
12
1
2020
medline:
26
8
2021
entrez:
12
1
2020
Statut:
ppublish
Résumé
AKT inhibitors have promising activity in
Identifiants
pubmed: 31924700
pii: 2159-8290.CD-19-1209
doi: 10.1158/2159-8290.CD-19-1209
pmc: PMC7125034
mid: NIHMS1550109
doi:
Substances chimiques
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
526-535Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
©2020 American Association for Cancer Research.
Références
J Clin Oncol. 2016 Jun 1;34(16):1872-81
pubmed: 26926684
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cell. 2017 Feb 9;168(4):584-599
pubmed: 28187282
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Nature. 2007 Jul 26;448(7152):439-44
pubmed: 17611497
Br J Cancer. 2008 May 6;98(9):1533-5
pubmed: 18392055
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Cancer Cell. 2018 Sep 10;34(3):427-438.e6
pubmed: 30205045
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
J Clin Oncol. 2016 Feb 10;34(5):419-26
pubmed: 26503204
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
J Clin Oncol. 2017 Jul 10;35(20):2251-2259
pubmed: 28489509
Science. 2019 Nov 8;366(6466):714-723
pubmed: 31699932
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
JAMA. 2019 Apr 9;321(14):1391-1399
pubmed: 30964529
Cancer Discov. 2019 Jan;9(1):OF7
pubmed: 30429128
Annu Rev Med. 2018 Jan 29;69:319-331
pubmed: 29120700